NIH consensus chronic GvHD following T-replete reduced-intensity conditioning sibling allograft usually develops within a year, causes prolonged morbidity but low mortality and is influenced by prophylactic methotrexate dose
Medd PG., Monk I., Danby R., Malladi R., Clifford R., Ellis A., Birks J., Roberts D., Hatton C., Vyas P., Littlewood TJ., Peniket AJ.